Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Eduardo, Tschen"'
Autor:
B. Elewski, S. Brand, T. Degenhardt, S. Curelop, R. Pollak, R. Schotzinger, A. Tavakkol, Javier Alonso‐Llamazares, Scott J. Ashton, Neal Bhatia, Michael Billings, Andrew Blauvelt, Norman Bystol, Brandt Dodson, Michael H. Gold, Kimberly Grande, Michael Jarratt, Terry S. Jones, Maria A. Kasper, Steven E. Kempers, Brock McConnehey, Michael Noss, David Pariser, Lawrence Parish, Phoebe Rich, Joseph Ahmad Samady, Joel Schlessinger, Doug Schumacher, Kenneth Stein, Cynthia Strout, Eduardo Tschen, John H. Tu, Max Weisfeld
Publikováno v:
The British journal of dermatologyReferences. 184(2)
BACKGROUND Onychomycosis is a fungal disease that affects the fingernails and toenails and is predominantly caused by dermatophytes. VT-1161 is a novel inhibitor of fungal CYP51 through the inhibition of lanosterol demethylase, and has demonstrated p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0225707b52f9abd6cd0998d7c888f102
https://pubmed.ncbi.nlm.nih.gov/32643171
https://pubmed.ncbi.nlm.nih.gov/32643171
Autor:
Angela, Moore, Lawrence J, Green, Suzanne, Bruce, Neil, Sadick, Eduardo, Tschen, Philip, Werschler, Fran E, Cook-Bolden, Sunil S, Dhawan, Douglass, Forsha, Michael H, Gold, Scott, Guenthner, Steven E, Kempers, Leon H, Kircik, Jennifer L, Parish, Marta I, Rendon, Phoebe, Rich, Linda, Stein-Gold, Stephen K, Tyring, Robert A, Weiss, Adnan, Nasir, Carsten, Schmitz, Terry I, Boodhoo, Alexandre, Kaoukhov, David R, Berk
Publikováno v:
Journal of drugs in dermatology : JDD. 17(9)
Side effects may limit the use of current tetracycline-class antibiotics for acne.Evaluate the efficacy and safety of once-daily sarecycline, a novel, narrow-spectrum tetracycline-class antibiotic, in moderate to severe acne.Patients 9-45 years with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d82139215e9f4f5d26f769f5bf923cae
https://pubmed.ncbi.nlm.nih.gov/30235387
https://pubmed.ncbi.nlm.nih.gov/30235387
Autor:
David, Pariser, Michael, Bukhalo, Scott, Guenthner, Steven, Kempers, Stephen, Shideler, Linda Stein, Gold, Eduardo, Tschen, Jim, Berg, Mary Beth, Ferdon, Syd, Dromgoole
Publikováno v:
Journal of drugs in dermatology : JDD. 16(3)
pBACKGROUND: A novel lotion formulation of halobetasol propionate, 0.05% (HBP Lotion) with enhanced vehicle characteristics of a cream while preserving the ease of use and cosmetic elegance of a lotion has been developed to treat plaque psoriasis.Det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::91fa25db59f315dd8a3881be96fe66b4
https://pubmed.ncbi.nlm.nih.gov/28301619
https://pubmed.ncbi.nlm.nih.gov/28301619
Autor:
Eduardo Tschen, Mary Spellman, Adelaide A. Hebert, Robert S. Call, Lawrence F. Eichenfield, Douglass W. Forsha, Linda Stein Gold, Joseph F. Fowler, Merrie Van Syoc, Lee T. Zane
Publikováno v:
Journal of the American Academy of Dermatology. 77(4)
Background Long-term topical treatment is often required for atopic dermatitis (AD), a chronic inflammatory skin disease. Objective To assess the long-term safety results from a multicenter, open-label, 48-week safety study (AD-303) of patients (N =
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26a2c9954cb6a4bc3204c78b027f955f
https://pubmed.ncbi.nlm.nih.gov/28823881
https://pubmed.ncbi.nlm.nih.gov/28823881
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 3:166
not available. Disclosures: Study sponsored by Aclaris.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::125bffe72f9699fef289977d92f39d20
https://doi.org/10.25251/skin.3.2.6
https://doi.org/10.25251/skin.3.2.6
Autor:
M.B.A. Eduardo Tschen M.D., Adelaide A. Hebert, B S Merrie Van Syoc, Leon Kircik, Zoe Diana Draelos, M.A.S. Lee T. Zane M.D., Robert Call, Sanjay Chanda
Publikováno v:
Pediatric Dermatology
Background Phosphodiesterase-4 (PDE4) is a promising target in atopic dermatitis (AD) treatment. The pharmacokinetics (PK), safety, and efficacy of crisaborole topical ointment, 2% (formerly AN2728) (Anacor Pharmaceuticals, Palo Alto, CA), a boron-ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7360df409a68cd4fb7dfdb31b9615746
https://pubmed.ncbi.nlm.nih.gov/27193740
https://pubmed.ncbi.nlm.nih.gov/27193740
Autor:
Lee T. Zane, Adelaide A. Hebert, Linda Stein Gold, Lawrence F. Eichenfield, Merrie Van Syoc, Douglass W. Forsha, Mary Spellman, Faad, Robert S. Call, Joseph F. Fowler, Eduardo Tschen
Publikováno v:
Pediatrics. 141:271-271
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting children and adults. Approximately 85% of patients develop AD by age 5 years, and long-term topical treatment is often required. Unfortunately, topical therapies are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f031a00bdbc6be6822f23664677b02f
https://doi.org/10.1542/peds.141.1ma3.271
https://doi.org/10.1542/peds.141.1ma3.271
Autor:
Mark Ling, W. Philip Werschler, Dow Stough, George J. Schmieder, Janelle Katsamas, Lawrence L. Anderson, Eduardo Tschen
Publikováno v:
Journal of the American Academy of Dermatology. 60:934-943
There is a need for improved medical approaches to the treatment of actinic keratosis. Ingenol mebutate, a diterpene ester extracted and purified from the plant Euphorbia peplus, is being evaluated as a topical therapy for actinic keratosis.Assess th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::433513140fdb63ecabbb382b84749015
https://doi.org/10.1016/j.jaad.2009.01.008
https://doi.org/10.1016/j.jaad.2009.01.008
Autor:
Ronald P. Savin, Phoebe Rich, Nicholas J. Lowe, Adelaide A Hebert, John J. DiGiovanna, Terry M. Jones, David Rodriguez, Sewon Kang, Jonathan Pak, Elyse S. Rafal, Graeme F. Bryce, Douglas R. Eberhardt, Lawrence F. Eichenfield, David M. Pariser, Stacy Smith, Michael Ondovik, Leena P. Shah, John A. McLane, Alan Menter, Mark Ling, Ko Chin Khoo, Julie Newhouse, Michael Jarratt, Craig B. Langman, Steven Kempers, Dan K. Chalker, Emily Wu, Eduardo Tschen, Sabra Sullivan, Catherine Chin
Publikováno v:
Journal of the American Academy of Dermatology. 51:709-717
Background Adverse changes in bone have been reported for patients undergoing high-dose, long-term (several years) isotretinoin therapy for disorders of cornification. The effect of short-term (4-5 months) therapy at the lower dose recommended for ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59feca6fc45d25a2d18d38aeaf40f86a
https://doi.org/10.1016/j.jaad.2004.04.032
https://doi.org/10.1016/j.jaad.2004.04.032
Autor:
Robert J. Pariser, Joseph J. Hong, John S. Strauss, Daniel Stewart, Terry M. Jones, Irving Katz, Jon M. Hanifin, Douglas Eberhardt, Graeme F. Bryce, Anne W. Lucky, Eduardo Tschen, David J. Baginski, Donald P. Lookingbill, David M. Pariser, Lawrence K. Chang, Steven Kempers, Michael Jarratt, Dan K. Chalker, Harry L. Roth, Nicholas J. Lowe, John Arthur Mclane, James J. Leyden, Ronald P. Savin, Elyse S. Rafal, Lynn A. Drake, Eileen E. Leach
Publikováno v:
Journal of the American Academy of Dermatology. 45:196-207
Background: Isotretinoin is a very effective drug for treating severe recalcitrant nodular acne. A new micronized formulation of isotretinoin has been shown to be clinically equivalent to standard isotretinoin with improved bioavailability and minima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83013d9ef8110b2fa6a965b95a59af0c
https://doi.org/10.1067/mjd.2001.115966
https://doi.org/10.1067/mjd.2001.115966